Financial reports
10-Q
2020 Q1
Quarterly report
1 May 20
10-K/A
2019 FY
Annual report (amended)
21 Apr 20
10-K
2019 FY
Annual report
2 Mar 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
13 May 19
10-K
2018 FY
Annual report
11 Mar 19
10-Q
2018 Q3
Quarterly report
13 Nov 18
10-Q
2018 Q2
Quarterly report
6 Aug 18
Current reports
8-K
BioNTech Completes Acquisition of Neon Therapeutics
6 May 20
8-K
Submission of Matters to a Vote of Security Holders
5 May 20
8-K
Other Events
29 Apr 20
8-K
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides
2 Mar 20
8-K
Form of Voting Agreement
16 Jan 20
8-K
Neon Therapeutics Reports Announces New Strategic Focus on Novel T Cell Programs
20 Nov 19
8-K
Neon Therapeutics Reports Third Quarter 2019 Financial Results
12 Nov 19
8-K
Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
8 Nov 19
8-K
Neon Therapeutics Reports Second Quarter 2019 Financial Results
6 Aug 19
8-K
Other Events
15 Jul 19
Registration and prospectus
15-12B
Securities registration termination
18 May 20
S-8 POS
Registration of securities for employees (post-effective amendment)
6 May 20
S-8 POS
Registration of securities for employees (post-effective amendment)
6 May 20
S-8 POS
Registration of securities for employees (post-effective amendment)
6 May 20
POS AM
Prospectus update (post-effective amendment)
6 May 20
25-NSE
Exchange delisting
6 May 20
425
Business combination disclosure
29 Apr 20
425
Business combination disclosure
31 Mar 20
425
Business combination disclosure
31 Mar 20
425
Business combination disclosure
31 Mar 20
Other
EFFECT
Notice of effectiveness
14 May 20
EFFECT
Notice of effectiveness
9 Jul 19
UPLOAD
Letter from SEC
8 Jul 19
CORRESP
Correspondence with SEC
3 Jul 19
CT ORDER
Confidential treatment order
19 Mar 19
EFFECT
Notice of effectiveness
27 Jun 18
CT ORDER
Confidential treatment order
27 Jun 18
CERT
Certification of approval for exchange listing
22 Jun 18
CORRESP
Correspondence with SEC
22 Jun 18
CORRESP
Correspondence with SEC
22 Jun 18